Search

Your search keyword '"Marais, A. David"' showing total 337 results

Search Constraints

Start Over You searched for: Author "Marais, A. David" Remove constraint Author: "Marais, A. David"
337 results on '"Marais, A. David"'

Search Results

2. Association of BMI, lipid-lowering medication, and age with prevalence of type 2 diabetes in adults with heterozygous familial hypercholesterolaemia: a worldwide cross-sectional study

3. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

11. Global perspective of familial hypercholesterolaemia: a cross-sectional study from the EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

12. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

15. The impact of type of dietary protein, animal versus vegetable, in modifying cardiometabolic risk factors: A position paper from the International Lipid Expert Panel (ILEP)

16. Statin therapy in athletes and patients performing regular intense exercise – Position paper from the International Lipid Expert Panel (ILEP)

17. Comparative aspects of the care of familial hypercholesterolemia in the “Ten Countries Study”

18. Familial hypercholesterolaemia in children and adolescents from 48 countries: a cross-sectional study

19. Overview of the current status of familial hypercholesterolaemia care in over 60 countries - The EAS Familial Hypercholesterolaemia Studies Collaboration (FHSC)

21. Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town

24. Effect of evolocumab on fasting and post fat load lipoprotein distribution and composition in familial dysbetalipoproteinemia

25. Pooling and expanding registries of familial hypercholesterolaemia to assess gaps in care and improve disease management and outcomes: Rationale and design of the global EAS Familial Hypercholesterolaemia Studies Collaboration

28. Composition and distribution of lipoproteins after evolocumab in familial dysbetalipoproteinemia. A randomized controlled trial

29. The association between a genetic variant in the SULF2 gene, metabolic parameters and vascular disease in patients at high cardiovascular risk.

30. Low-density lipoprotein cholesterol and non-high-density lipoprotein cholesterol measurement in Familial Dysbetalipoproteinemia

31. Effect of evolocumab on fasting and post fat load lipids and lipoproteins in familial dysbetalipoproteinemia

35. Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study

36. Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in theAPOEgene

37. Establishing the relationship between familial dysbetalipoproteinemia and genetic variants in the APOE gene

38. Clinical heterogeneity in monogenic chylomicronaemia

46. Impact of nutraceuticals on markers of systemic inflammation: Potential relevance to cardiovascular diseases – A position paper from the International Lipid Expert Panel (ILEP)

47. Simvastatin with or without Ezetimibe in familial Hypercholesterolemia

48. Novel PCSK9 (Proprotein Convertase Subtilisin Kexin Type 9) Variants in Patients With Familial Hypercholesterolemia From Cape Town

Catalog

Books, media, physical & digital resources